Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.86
Vanguard Group, Inc. (Subfiler) 8.67
The Vanguard Group, Inc. 8.29
State Street Corp. 4.42
Vanguard Total Stock Market ETF 3.13
BlackRock Fund Advisors 2.97
Vanguard 500 Index Fund 2.41
Capital Research & Management Co. (International Investors) 2.40
BlackRock Institutional Trust Co. NA 2.22
JPMorgan Investment Management, Inc. 2.20
Geode Capital Management LLC 2.05
Capital Research & Management Co. (Global Investors) 1.81
Charles Schwab Investment Management, Inc. 1.29
Fidelity 500 Index Fund 1.15
Norges Bank (13F) 1.06

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2018 2019 2020 2021 2022
Personal am Ende des Jahres 30'000 30'000 47'000 50'000 50'000
Umsatz pro Mitarbeiter in Mio. EUR 1.09 1.11 0.97 1.12 1.16

Bilanz (in Mio. EUR) - Aktiva

2018 2019 2020 2021 2022
Summe Umlaufvermögen 16'945 49'519 24'173 27'928 28'463
Summe Anlagevermögen 31'864 58'916 100'139 92'983 81'445
Summe Aktiva 59'352 89'115 150'565 146'529 138'805

Bilanz (in Mio. EUR) - Passiva

2018 2019 2020 2021 2022
Gesamtverschuldung/ -verbindlichkeiten 40'310 67'088 87'063 77'575 64'191
Summe Fremdkapital 67'798 97'287 137'468 131'093 121'518
Summe Eigenkapital -8'446 -8'172 13'097 15'436 17'287
Summe Passiva 59'352 89'115 150'565 146'529 138'805

Adresse

1 North Waukegan Road, 60064-6400 North Chicago
Telefon +1 (847) 932-7900
URL http://www.abbvie.com

Management

Azita Saleki-Gerhardt
Executive Vice President-Operations
Brett J. Hart
Independent Director
Brian L. Durkin
Vice President
Carrie Strom
Senior VP & President-Global Allergan Aesthetics
Chris Boone
Vice President & Global Head-Health Economics
Edward J. Rapp
Independent Director
Esteban Plata
Vice President-Western Europe & Canada
Frederick H. Waddell
Independent Director
Glenn Fletcher Tilton
Lead Independent Director
Jeffrey Ryan Stewart
Chief Commercial Officer & Executive VP
Jennifer L. Davis
Independent Director
Katherine Rielly-Gauvin
Vice President-Global Commercial Development
Kevin K. Buckbee
Senior Vice President & Controller
Liz Shea
Head-Investor Relations
Melody B. Meyer
Independent Non-Executive Director
Perry C. Siatis
Secretary, Executive VP & General Counsel
Rebecca Brown Roberts
Independent Director
Richard A. Gonzalez
Chairman & Chief Executive Officer
Robert A. Michael
Vice Chairman, President & Chief Operating Officer
Robert J. Alpern
Independent Director
Roxanne Schuh Austin
Independent Director
Scott T. Reents
Chief Financial Officer & Executive Vice President
Susan E. Quaggin
Independent Director
Thomas C. Freyman
Independent Director
Thomas J. Hudson
Chief Scientific Officer, Senior VP-R&D
Timothy J. Richmond
Chief Human Resources Officer & Executive VP
Todd D. Bosse
Vice President-Investor Relations
William H. L. Burnside
Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen